WO2008022962A3 - Verfahren zur herstellung von n-piperidinyl-benzodiazepinen mit cgrp-antagonistischen eigenschaften - Google Patents

Verfahren zur herstellung von n-piperidinyl-benzodiazepinen mit cgrp-antagonistischen eigenschaften Download PDF

Info

Publication number
WO2008022962A3
WO2008022962A3 PCT/EP2007/058526 EP2007058526W WO2008022962A3 WO 2008022962 A3 WO2008022962 A3 WO 2008022962A3 EP 2007058526 W EP2007058526 W EP 2007058526W WO 2008022962 A3 WO2008022962 A3 WO 2008022962A3
Authority
WO
WIPO (PCT)
Prior art keywords
cgrp
benzodiazepines
piperidinyl
producing
antagonistic properties
Prior art date
Application number
PCT/EP2007/058526
Other languages
English (en)
French (fr)
Other versions
WO2008022962A2 (de
Inventor
Guenther Huchler
Werner Rall
Uwe Ries
Original Assignee
Boehringer Ingelheim Int
Boehringer Ingelheim Pharma
Guenther Huchler
Werner Rall
Uwe Ries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int, Boehringer Ingelheim Pharma, Guenther Huchler, Werner Rall, Uwe Ries filed Critical Boehringer Ingelheim Int
Priority to EP07802657A priority Critical patent/EP2057142A2/de
Priority to AU2007287584A priority patent/AU2007287584A1/en
Priority to BRPI0715822-0A priority patent/BRPI0715822A2/pt
Priority to MX2009001168A priority patent/MX2009001168A/es
Priority to JP2009525031A priority patent/JP2010501517A/ja
Priority to CA002661778A priority patent/CA2661778A1/en
Publication of WO2008022962A2 publication Critical patent/WO2008022962A2/de
Priority to IL197022A priority patent/IL197022A0/en
Publication of WO2008022962A3 publication Critical patent/WO2008022962A3/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Gegenstand der vorliegenden Erfindung ist ein Verfahren zur Herstellung von Verbindungen der allgemeinen Formel (I), in der R1 und R2 wie in Anspruch 1 definiert sind, deren pharmazeutisch verträglichen Salze und den Solvaten davon, die ausgehend von Verbindungen der allgemeinen Formel (II), in der R1 wie in Anspruch 1 definiert ist, hergestellt werden können.
PCT/EP2007/058526 2006-08-19 2007-08-16 Verfahren zur herstellung von n-piperidinyl-benzodiazepinen mit cgrp-antagonistischen eigenschaften WO2008022962A2 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EP07802657A EP2057142A2 (de) 2006-08-19 2007-08-16 Verfahren zur herstellung von n-piperidinyl-benzodiazepinen mit cgrp-antagonistischen eigenschaften
AU2007287584A AU2007287584A1 (en) 2006-08-19 2007-08-16 Method for producing N-piperidinyl-benzodiazepines having CGRP-antagonistic properties
BRPI0715822-0A BRPI0715822A2 (pt) 2006-08-19 2007-08-16 processo de preparaÇço
MX2009001168A MX2009001168A (es) 2006-08-19 2007-08-16 Nuevo procedimiento de preparacion.
JP2009525031A JP2010501517A (ja) 2006-08-19 2007-08-16 新規製造方法
CA002661778A CA2661778A1 (en) 2006-08-19 2007-08-16 New production method
IL197022A IL197022A0 (en) 2006-08-19 2009-02-12 Novel preparation method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006039038A DE102006039038A1 (de) 2006-08-19 2006-08-19 Neues Herstellungsverfahren
DE102006039038.5 2006-08-19

Publications (2)

Publication Number Publication Date
WO2008022962A2 WO2008022962A2 (de) 2008-02-28
WO2008022962A3 true WO2008022962A3 (de) 2009-03-05

Family

ID=38954945

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/058526 WO2008022962A2 (de) 2006-08-19 2007-08-16 Verfahren zur herstellung von n-piperidinyl-benzodiazepinen mit cgrp-antagonistischen eigenschaften

Country Status (17)

Country Link
US (3) US7696346B2 (de)
EP (1) EP2057142A2 (de)
JP (2) JP2010501517A (de)
KR (1) KR20090055004A (de)
CN (1) CN101600705A (de)
AR (1) AR063692A1 (de)
AU (1) AU2007287584A1 (de)
BR (1) BRPI0715822A2 (de)
CA (1) CA2661778A1 (de)
CL (1) CL2007002408A1 (de)
DE (1) DE102006039038A1 (de)
IL (1) IL197022A0 (de)
MX (1) MX2009001168A (de)
RU (1) RU2009109745A (de)
TW (1) TW200817344A (de)
WO (1) WO2008022962A2 (de)
ZA (1) ZA200810783B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010048138A1 (en) * 2008-10-21 2010-04-29 Boehringer Ingelheim International Gmbh Synthesis of intermediates useful for the production of certain cgrp inhibitors and intermediates used in such synthesis
JP7140347B2 (ja) * 2016-06-09 2022-09-21 有機合成薬品工業株式会社 4-(ピペリジン-4-イル)モルホリンの製造方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1310488A1 (de) * 2000-08-09 2003-05-14 Mitsubishi Pharma Corporation Kondensierte bizyklische amidverbindungen und ihre medizinische verwendung
WO2005092880A1 (de) * 2004-03-29 2005-10-06 Boehringer Ingelheim International Gmbh Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
EP1770087A1 (de) * 2005-09-29 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co. KG Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
WO2008060568A2 (en) * 2006-11-15 2008-05-22 Neurogen Corporation Amide-substituted aryl piperidines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082847A (en) * 1990-07-18 1992-01-21 Syntex (U.S.A.) Inc. Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility
CA2555594A1 (en) * 2004-02-10 2005-08-25 Janssen Pharmaceutica N.V. Pyridazinones as antagonists of a4 integrins

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1310488A1 (de) * 2000-08-09 2003-05-14 Mitsubishi Pharma Corporation Kondensierte bizyklische amidverbindungen und ihre medizinische verwendung
WO2005092880A1 (de) * 2004-03-29 2005-10-06 Boehringer Ingelheim International Gmbh Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
EP1770087A1 (de) * 2005-09-29 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co. KG Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
WO2008060568A2 (en) * 2006-11-15 2008-05-22 Neurogen Corporation Amide-substituted aryl piperidines

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHRISTOPHE DARDONVILLE, ISABEL ROZAS, PILAR GOYA, ROCIO GIRON, CARLOS GOICOECHEA, MA. ISABEL ,MARTINI: "Synthesis and analgesic activity of a series of new azaalkane bis-guanidinium and bis(2-aminoimidazolinium) compounds", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 11, 2003, pages 1283 - 1291, XP002508636 *
H. A. STAAB, W. ROHR: "Syntheses using Heterocyclic Amides (Azolides)", NEWER METHODS PREP. ORG. CHEM., vol. 5, 1968, pages 61 - 108, XP009095624 *
PAULINE C. TING, JOE F. LEE, JOHN C. ANTHES, NENG-YANG SHIH, JOHN J. PIWINSKI: "Synthesis of substituted 4(Z)-(methoxyimino)pentyl-1-piperidines as dual NK1/NK2 inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 11, 2001, pages 491 - 494, XP002508634 *
RICHARD F. BORCH, MARK. D. BERNSTEIN, H. DUPONT DURST: "The cyanohydridoborate anion as a selective reducing agent", J. AM. CHEM. SOC., vol. 93, no. 12, 1971, pages 2897 - 2904, XP002508635 *

Also Published As

Publication number Publication date
RU2009109745A (ru) 2010-09-27
EP2057142A2 (de) 2009-05-13
JP2012232980A (ja) 2012-11-29
US8084634B2 (en) 2011-12-27
CL2007002408A1 (es) 2008-05-16
CA2661778A1 (en) 2008-02-28
US7696346B2 (en) 2010-04-13
MX2009001168A (es) 2009-02-10
BRPI0715822A2 (pt) 2013-07-23
KR20090055004A (ko) 2009-06-01
US8119797B2 (en) 2012-02-21
WO2008022962A2 (de) 2008-02-28
US20100152439A1 (en) 2010-06-17
US20110295000A1 (en) 2011-12-01
DE102006039038A1 (de) 2008-02-21
IL197022A0 (en) 2009-11-18
ZA200810783B (en) 2010-08-25
TW200817344A (en) 2008-04-16
CN101600705A (zh) 2009-12-09
AU2007287584A1 (en) 2008-02-28
AR063692A1 (es) 2009-02-11
JP2010501517A (ja) 2010-01-21
US20080045705A1 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
WO2007133183A3 (en) Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors
WO2008085575A3 (en) Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors
WO2006113509A3 (en) Quinobenzoxazine analogs and methods of using thereof
WO2007009656A3 (de) Neues 1,4-benzothiazepin-1,1-dioxidderivat mit verbesserten eigenschaften, verfahren zu dessen herstellung, diese verbindung enthaltende arzneimittel und dessen verwendung
WO2009002427A3 (en) Methods of synthesizing cinacalcet and salts thereof
WO2007135527A3 (en) Benzimidazolyl compounds
UA99361C2 (uk) ТРИАЗИНИ ЯК ІНГІБІТОРИ PІ3-КІНАЗИ І mTOR
WO2006072393A3 (de) Sulfonylpyrrolidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2008044243A3 (en) Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof
WO2008001195A3 (en) Novel processes for the preparation of dpp iv inhibitors
WO2008022286A3 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
WO2007133184A3 (en) Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors
UA99447C2 (ru) Способ получения силденафила
WO2007147771A3 (en) Tetralin and indane derivatives and uses thereof
WO2007017728A3 (en) Novel heterocyclic compounds
WO2006066044A3 (en) Processes for producing 4-aminoquinazolines
WO2009056707A3 (fr) Dérivés de l'ind0l-2-0ne disubstitues en 3, leur preparation et leur application en thérapeutique
WO2007131907A3 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
AU2010321366A8 (en) Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
WO2008145524A3 (en) 4,4-disubstituted piperidine derivatives
WO2009021943A3 (de) Neues herstellverfahren
WO2004111008A3 (en) Use of a compound of formula i for making a pharmaceutical composition
WO2009075516A3 (en) Process for preparing pantoprazole sodium sesquihydrate
WO2008059513A3 (en) Compounds suitable as modulators of hdl
WO2009076602A8 (en) 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780030188.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07802657

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2007802657

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: MX/A/2009/001168

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 197022

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2661778

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2009525031

Country of ref document: JP

Ref document number: 12009500332

Country of ref document: PH

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 1278/DELNP/2009

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2007287584

Country of ref document: AU

Ref document number: 575547

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 2009109745

Country of ref document: RU

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020097005684

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 2007287584

Country of ref document: AU

Date of ref document: 20070816

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: PI0715822

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20090219